Barchart.com
[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Cardiol Therapeutics Inc (CRDL.TO)

Cardiol Therapeutics Inc (CRDL.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Stocks in play: Cardiol Therapeutics Inc. Baystreet - Thu Jun 25, 9:00AM CDT

Announces the results from its Annual General Meeting of Shareholders held virtually via live audio ...

CRDL.TO : 1.49 (-1.32%)
Cardiol Therapeutics Reports Results of 2026 Annual General Meeting of Shareholders PR Newswire - Thu Jun 25, 6:27AM CDT

TORONTO , June 25, 2026 /CNW/ - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a late-stage life sciences company advancing anti-inflammatory and anti-fibrotic...

CRDL.TO : 1.49 (-1.32%)
CRDL : 1.0300 (-0.96%)
Cardiol Therapeutics Reports Results of 2026 Annual General Meeting of Shareholders PR Newswire - Thu Jun 25, 6:27AM CDT

TORONTO , June 25, 2026 /PRNewswire/ - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a late-stage life sciences company advancing anti-inflammatory and anti-fibrotic...

CRDL.TO : 1.49 (-1.32%)
CRDL : 1.0300 (-0.96%)
Stocks in play: Cardiol Therapeutics Inc. Baystreet - Tue Jun 23, 9:05AM CDT

Announces that the Company's virtual Annual General Meeting of Shareholders will be webcast on June ...

CRDL.TO : 1.49 (-1.32%)
Cardiol Therapeutics to Webcast Virtual Annual General Meeting of Shareholders on June 24th at 4:30 p.m. EDT PR Newswire - Tue Jun 23, 6:27AM CDT

TORONTO , June 23, 2026 /PRNewswire/ - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a late-stage life sciences company advancing anti-inflammatory and anti-fibrotic...

CRDL.TO : 1.49 (-1.32%)
CRDL : 1.0300 (-0.96%)
Stocks in play: Cardiol Therapeutics Inc. Baystreet - Thu May 14, 10:54AM CDT

Will participate in a Fireside Chat at the H.C. Wainwright 4th Annual BioConnect Investor Conference ...

CRDL.TO : 1.49 (-1.32%)
Cardiol Therapeutics to Participate in Fireside Chat at H.C. Wainwright 4th Annual BioConnect Investor Conference at the NASDAQ PR Newswire - Thu May 14, 6:27AM CDT

TORONTO , May 14, 2026 /PRNewswire/ - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) (" Cardiol " or the " Company "), a late-stage life sciences company advancing anti-inflammatory...

CRDL.TO : 1.49 (-1.32%)
CRDL : 1.0300 (-0.96%)
Stocks in play: Cardiol Therapeutics Inc. Baystreet - Thu May 7, 8:58AM CDT

Today announced that the results from its Phase II study evaluating CardiolRx™ in patients with recurrent ...

CRDL.TO : 1.49 (-1.32%)
Cardiol Therapeutics' Phase II MAvERIC Results Accepted for Publication in the Journal of the American Heart Association PR Newswire - Thu May 7, 6:27AM CDT

TORONTO, ON , May 7, 2026 /CNW/ - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a late-stage life sciences company advancing anti-inflammatory and anti-fibrotic...

CRDL.TO : 1.49 (-1.32%)
CRDL : 1.0300 (-0.96%)
Cardiol Therapeutics' Phase II MAvERIC Results Accepted for Publication in the Journal of the American Heart Association PR Newswire - Thu May 7, 6:27AM CDT

TORONTO, ON , May 7, 2026 /PRNewswire/ - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a late-stage life sciences company advancing anti-inflammatory and anti-fibrotic...

CRDL.TO : 1.49 (-1.32%)
CRDL : 1.0300 (-0.96%)

Barchart Exclusives

This Lesser-Known Dividend Stock Is Beating the S&P 500 in 2026 and Yields More Than 3% Barchart - Mon Jun 29, 6:30PM CDT
Watsco has raised its quarterly dividend by 10% to $3.30 per share, lifting the annualized payout to $13.20 and delivering a forward yield above 3%. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.